Regulation of glut1 mRNA by hypoxia-inducible factor-1. Interaction between H-ras and hypoxia

J Biol Chem. 2001 Mar 23;276(12):9519-25. doi: 10.1074/jbc.M010144200. Epub 2000 Dec 18.

Abstract

Oncogenic transformation and hypoxia both induce glut1 mRNA. We studied the interaction between the ras oncogene and hypoxia in up-regulating glut1 mRNA levels using Rat1 fibroblasts transformed with H-ras (Rat1-ras). Transformation with H-ras led to a substantial increase in glut1 mRNA levels under normoxic conditions and additively increased glut1 mRNA levels in concert with hypoxia. Using a luciferase reporter construct containing 6 kilobase pairs of the glut1 promoter, we showed that this effect was mediated at the transcriptional level. Promoter activity was much higher in Rat1-ras cells than in Rat1 cells and could be down-regulated by cotransfection with a dominant negative Ras construct (RasN17). A 480-base pair (bp) cobalt/hypoxia-responsive fragment of the promoter containing a HIF-1 binding site showed significantly higher activity in Rat1-ras cells than in Rat1 cells, suggesting that Ras might mediate its effect through HIF-1 even under normoxic conditions. Consistent with this, Rat1-ras cells displayed higher levels of HIF1-alpha protein under normoxic conditions. In addition, a promoter construct containing a 4-bp mutation in the HIF1 binding site showed lower activity in Rat1-ras cells than a construct with an intact HIF1 binding site. The activity of the latter construct but not the former could be down-regulated by RasN17, supporting the importance of the HIF1 binding site in regulation by Ras. The phosphatidylinositol 3-kinase inhibitor LY29004 down-regulated glut1 promoter activity and mRNA levels under normoxia and also decreased HIF1alpha protein levels in these cells. Collectively these results indicate that H-Ras up-regulates the glut1 promoter, at least in part, by increasing HIF-1alpha protein levels leading to transactivation of promoter through the HIF-1 binding site.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Base Sequence
  • Cell Line, Transformed
  • Chromones / pharmacology
  • DNA
  • DNA-Binding Proteins / metabolism
  • DNA-Binding Proteins / physiology*
  • Down-Regulation / drug effects
  • Enzyme Inhibitors / pharmacology
  • Flavonoids / pharmacology
  • Gene Expression Regulation / physiology*
  • Glucose Transporter Type 1
  • Hypoxia / metabolism*
  • Hypoxia-Inducible Factor 1
  • Hypoxia-Inducible Factor 1, alpha Subunit
  • Mitogen-Activated Protein Kinases / antagonists & inhibitors
  • Molecular Sequence Data
  • Monosaccharide Transport Proteins / genetics*
  • Morpholines / pharmacology
  • Nuclear Proteins / metabolism
  • Nuclear Proteins / physiology*
  • Oncogene Protein p21(ras) / metabolism*
  • Phosphoinositide-3 Kinase Inhibitors
  • Promoter Regions, Genetic
  • Protein Binding
  • RNA, Messenger / genetics*
  • Rats
  • Transcription Factors*

Substances

  • Chromones
  • DNA-Binding Proteins
  • Enzyme Inhibitors
  • Flavonoids
  • Glucose Transporter Type 1
  • Hif1a protein, rat
  • Hypoxia-Inducible Factor 1
  • Hypoxia-Inducible Factor 1, alpha Subunit
  • Monosaccharide Transport Proteins
  • Morpholines
  • Nuclear Proteins
  • Phosphoinositide-3 Kinase Inhibitors
  • RNA, Messenger
  • Slc2a1 protein, rat
  • Transcription Factors
  • 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one
  • DNA
  • Mitogen-Activated Protein Kinases
  • Oncogene Protein p21(ras)
  • 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one